Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Thursday is World Diabetes Day. Diabetes affects 40 million Americans and for most, the best form of treatment includes ...

The pancreas holds a unique position as both an endocrine and exocrine organ. It plays an important role in managing blood sugar levels through insulin. Sir Fredrick Banting’s birth anniversary is ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

On World Diabetes Day (November 14) the city’s university has announced it has teamed up with the University of Leeds to ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Combined with Zomedica's eACTH assay, equine veterinarians get same day answers for their PPID and EMS patients ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

On World Diabetes Day, we explore the links between stress hormones and diabetes and what this could mean for future ...

Stress may be the reason people with obesity are more likely to get other metabolic diseases, such as type 2 diabetes, ...